Experience of using vasoactive therapy in patients with stage I-II venous discirculatory encephalopathy

Introduction. We present the results of our own observational cohort study of patients with stage I-II discirculatory encephalopathy treated with a combination of dihydroergocriptine and caffeine (Vazobral®). Interest in this issue is due to the fact that cerebrospinal venous insufficiency plays a role in the pathogenesis of neurodegenerative and vascular diseases of the brain, leading to the development of cognitive impairment, the formation of secondary headaches, and reducing the quality of life of patients.

The purpose of the study was to evaluate the effectiveness and safety of the drug Vazobral® in patients with stage I-II discirculatory encephalopathy due to venous discirculation in the presence of chronic cerebrospinal venous insufficiency.

Material and methods: 102 outpatients (average age 63.5 ± 3.74 years, 25 (25.5%) men and 77 (74.5%) women) suffering from chronic cerebral ischemia and having signs of chronic cerebrospinal venous insufficiency . Stage I dyscirculatory encephalopathy with mild cognitive impairment was diagnosed in 58 (59.2%) patients, stage II dyscirculatory encephalopathy with mild cognitive impairment was diagnosed. All observed had a duplex scan of the branches of the aortic arch, jugular and vertebral veins, with a measurement of the linear velocity of blood flow; the intensity of headaches, cognitive status, the severity of affective syndrome using special questionnaires were evaluated. For 3 months, patients took Vazobral® 8/80 mg per day. The data obtained were analyzed using computer programs SPSS and Statistica. Significance of differences – with a 95% CI, p <0.05.

Results. Significant positive dynamics was observed in patients with Vazobral®: a decrease in headache intensity (from 4.11 to 0.67 points), cognitive function assessment increased by 14% from the initial level, the severity of the anxiety-depressive symptom complex, significantly decreased by 38–56%

Conclusion. The drug Vazobral® can be recommended to increase the effectiveness of the treatment of patients suffering from stage I-II discirculatory encephalopathy with venous discirculation phenomena. 

1. Beggs C.B. Venous hemodynamics in neurological disorders: an analytical review with hydrodynamic analysis. BMC Med. 2013;11:142. doi: 10.1186/1741-7015-11-142

2. Frydrychowski A.F., Winklewski P.J., Guminski W. Influence of acute jugular vein compression on the cerebral blood flow velocity, pial artery pulsation and width of subarachnoid space in humans. PLoS One. 2012;7:e48245. doi: 10.1371/journal.pone.0048245.

3. Chukanova E.I., Mamaeva H.I., Chukanova A.S. Treatment of chronic cerebral venous insufficiency: a study on an effect of L-lysine aescinat. Zhurnal nevrologii i psihiatrii = Journal of Neurology and Psychiatry. 2016;(7):37-41. (In Russ.) doi: 10.17116/ jnevro20161167137-41.

4. Zamboni P., Menegatti E., Weinstock-Guttman B., Schirda C., Cox J.L., Malagoni A.M. et al. The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics. Funct Neurol. 2009;24(3):133-8. Available at: https://www.ncbi.nlm.nih.gov/ pubmed/20018140.

5. Zamboni P., Menegatti E., Conforti P., Shepherd S., Tessari M., Beggs C. Assessment of cerebral venous return by a novel plethysmography method. J Vasc Surg. 2012;56:677–685. doi: 10.1016/j.jvs.2012.01.074.

6. Zivadinov R., Poloni G.U., Marr K., Schirda C.V., Magnano C.R., Carl E. et al. Decreased brain venous vasculature visibility on susceptibilityweighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency. BMC Neurol. 2011;11:128. • doi: 10.1186/14712377-11-12.

7. Bateman G.A. Pulse-wave encephalopathy: a comparative study of the hydrodynamics of leukoaraiosis and normal-pressure hydrocephalus. Neuroradiology. 2002;44:740–748. Available at: https://www.ncbi.nlm.nih.gov/ pubmed/12221445.

8. Bateman G.A., Lechner-Scott J., Lea R.A. A comparison between the pathophysiology of multiple sclerosis and normal pressure hydrocephalus: is pulse wave encephalopathy a component of MS? Fluids Barriers CNS. 2016;13:18. doi: 10.1186/s12987-016-0041-2.

9. Han K., Chao A.C., Chang F.C., Chung C.P., Hsu H.Y., Sheng W.Y., Wu J., Hu H.H. Obstruction of Venous Drainage Linked to Transient Global Amnesia. PLoS One. 2015;10(7):e0132893. doi: 10.1371/journal.pone.0132893.

10. Han K., Hu H.H., Chao A.C., Chang F.C., Chung C.P., Hsu H.Y., Sheng W.Y., Wu J. Transient Global Amnesia Linked to Impairment of Brain Venous Drainage: An Ultrasound Investigation. Front Neurol. 2019;10:67. doi: 10.3389/fneur.2019.00067 .

11. Mariaca A.F., Valdueza J.M., Gaebel C., GomezChoco M. Simultaneous transient global amnesia and right MCA stroke after Valsalva manoeuvre. BMJ Case Rep. 2017;2017:bcr2016218990. doi: 10.1136/bcr2016-218990.

12. Cheng C.Y., Chang F.C., Chao A.C., Chung C.P., Hu H.H. Internal jugular venous abnormalities in transient monocular blindness. BMC Neurol. 2013;13:94. doi: 10.1186/1471-2377-13-94.

13. Chung C.P., Hsu H.Y., Chao A.C., Cheng C.Y., Lin S.J., Hu H.H. Jugular venous reflux affects ocular venous system in transient monocular blindness. Cerebrovasc Dis. 2010;29(2):122-129. doi: 10.1159/000262307 .

14. Zivadinov R Is there a link between the extracranial venous system and central nervous system pathology? BMC Med. 2013;11:259. doi: 10.1186/1741-7015-11-259.

15. Liu M., Xu H., Wang Y., Zhong Y., Xia S. Patterns of chronic venous insufficiency in the dural sinuses and extracranial draining veins and their relationship with white matter hyperintensities for patients with Parkinson’s disease. Journal of Vascular Surgery. 2015;61(6):15111520.e1. doi: 10.1016/j.jvs.2014.02.021.

16. Chung C.P., Wang P.N., Wu Y.H., Tsao Y.C., Sheng W.Y., Lin K.N., Lin S.J., Hu H.H. More severe white matter changes in the elderly with jugular venous reflux. Ann Neurol. 2011;69:553– 559. doi: 10.1002/ana.22276.

17. Gorelick Ph.B., Counts S.E., Nyenhuisc D. Vascular cognitive impairment and dementia Biochim Biophys Acta. 2016;1862(5):860–868. doi: 10.1016/j.bbadis.2015.12.015.

18. Zhou M., Mao L., Wang Y., Wang Q., Yang Z., Li S., Li L. Morphologic changes of cerebral veins in hypertensive rats: venous collagenosis is associated with hypertension. J Stroke Cerebrovasc Dis. 2015;24:530–536. doi: 10.1016/j.jstrokecerebrovasdis.2014.09.038.

19. Henry-Feugeas M.C., Koskas P. Cerebral vascular aging: extending the concept of pulse wave encephalopathy through capillaries to the cerebral veins. Curr Aging Sci. 2012;5:157– 167. doi: 10.2174/1874609811205020157 .

20. Toro E.F. Brain venous haemodynamics, neurological diseases and mathematical modelling. A review Applied Mathematics and Computation. 2016; 272(Part 2):542-579. doi: 10.1016/j. amc.2015.06.066.

21. Elliott J.M., Grahame-Smith D.G. The binding characteristics of [3H]-dihydroergocryptine on intact human platelets. Br J Pharmacol. 1982;76(1):121–130. Available at: https:// www.ncbi.nlm.nih.gov/pmc/articles/ PMC2068753.

22. Kerry R., Scrutton M.C. Effect of 781094, a new selective alpha-adrenoceptor antagonist, on the aggregatory responses of human blood platelets and on binding of [3H]-dihydroergocryptine to these cells. Br J Pharmacol. 1983;79(2):401–407. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC2044865.

23. Levin O.S., Barantsevich E.R., Bel’skaia G.N., Vasenina E.E. et al. Efficacy of the combination drug vasobral in chronic vascular encephalopathy. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova S.S. = Korsakov Journal of Neurology and Psychiatry. 2014;(10):25-29. (In Russ.) Available at: https://www.mediasphera. ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-ss-korsakova/2014/10/031997-72982014105.

24. Levin O.S., Chimagomedova A.S., Polyakova T.A., Arablinsky A.V. 60 years towards definition of dyscirculatory (vascular) encephalopathy: can we put new wine into old wineskins? Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova S.S. = Korsakov Journal of Neurology and Psychiatry. 2018;(6):13-26. (In Russ.) doi.org/10.17116/jnevro201811806213.